NRx Inventory Turnover from 2010 to 2024

NRXPW Stock  USD 0.05  0  3.59%   
NRx Pharmaceuticals Inventory Turnover yearly trend continues to be fairly stable with very little volatility. Inventory Turnover is likely to outpace its year average in 2024. Inventory Turnover is a ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management. View All Fundamentals
 
Inventory Turnover  
First Reported
2010-12-31
Previous Quarter
(0.66)
Current Value
(0.62)
Quarterly Volatility
2.21825313
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NRx Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NRx Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.8 K, Interest Expense of 114 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NRx financial statements analysis is a perfect complement when working with NRx Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of NRx Pharmaceuticals Correlation against competitors.
For more information on how to buy NRx Stock please use our How to Invest in NRx Pharmaceuticals guide.

Latest NRx Pharmaceuticals' Inventory Turnover Growth Pattern

Below is the plot of the Inventory Turnover of NRx Pharmaceuticals over the last few years. It is a ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management. NRx Pharmaceuticals' Inventory Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NRx Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Inventory Turnover10 Years Trend
Slightly volatile
   Inventory Turnover   
       Timeline  

NRx Inventory Turnover Regression Statistics

Arithmetic Mean2.95
Geometric Mean2.52
Coefficient Of Variation75.25
Mean Deviation1.90
Median4.24
Standard Deviation2.22
Sample Variance4.92
Range4.9002
R-Value(0.77)
Mean Square Error2.17
R-Squared0.59
Significance0.0008
Slope(0.38)
Total Sum of Squares68.89

NRx Inventory Turnover History

2024 -0.62
2023 -0.66
2021 -0.57

About NRx Pharmaceuticals Financial Statements

NRx Pharmaceuticals investors use historical fundamental indicators, such as NRx Pharmaceuticals' Inventory Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NRx Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Inventory Turnover(0.66)(0.62)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NRx Stock Analysis

When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.